Markets

  • Helius Medical Technologies Sets Price for $9.1 Million Public Offering

    Helius Medical Technologies has priced its public offering, offering 2,768,600 shares of Class A common stock equivalents with warrants for an additional 2,768,600 shares at $3.27 per unit. Warrants have a 2.5-year lifespan and an initial exercise price of $7.35. The offering is expected to close June 6, 2025, with gross proceeds of $9.1 million. Maxim Group LLC is the placement agent.

    2025年6月4日
  • 360 Reveals Taiwanese Military’s Cyber Units and Five Major Hacker Groups

    A recent report accuses five Taiwanese cyber espionage groups (APT-C-01, 62, 64, 65, and 67) of orchestrating attacks on mainland systems. The report, which directly links these groups to Taiwan’s “Cyber Warfare Unit,” highlights APT-C-67 (Ursula)’s alleged involvement in recent attacks, including targeting critical infrastructure. Experts note the groups utilize known vulnerabilities and rely on less sophisticated techniques, making them easier to detect. The report also highlights broader cyber threats and emphasizes AI’s role in future cybersecurity.

    2025年6月4日
  • Apple to Appeal Rejection of App Store Suspension Request

    The Ninth Circuit Court of Appeals denied Apple’s request to stay a lower court order concerning its App Store operations. This ruling impacts Apple’s ability to control in-app purchases by disallowing developers to direct users to external payment options. The ongoing antitrust battle, initiated by Epic Games, is the root of this legal dispute. Apple plans to appeal the decision, disagreeing with the ruling that they violated a previous court order promoting market competition.

    2025年6月4日
  • HUTCHMED and Innovent: China Accepts NDA for Fruquintinib Plus Sintilimab in Advanced Renal Cell Carcinoma

    HUTCHMED and Innovent Biologics announced the NMPA acceptance of a New Drug Application for fruquintinib and sintilimab combination therapy. This targets advanced renal cell carcinoma patients who failed prior tyrosine kinase inhibitor treatment. Based on positive FRUSICA-2 trial results, it met its primary endpoint of progression-free survival. The therapy may address the unmet needs for second-line treatment, with ongoing research to expand its applications and indications in immuno-oncology.

    2025年6月4日
  • Americans, Resist! Trump Targets Musk’s Tesla with Devastating Legislation

    Elon Musk’s criticism of Republican tax and spending plans has reportedly strained his relationship with Donald Trump. Disagreement over proposed legislation impacting Tesla and the electric vehicle industry, including fees for EV owners and elimination of tax credits, has fueled the tension. Musk, expressing concerns about “debt slavery,” has actively campaigned against the proposals, potentially damaging a previous close collaboration with Trump, who is reportedly displeased with the shift.

    2025年6月4日
  • Targa Resources Corp. Announces $1.5 Billion Senior Notes Offering

    Targa Resources Corp. announced a $1.5 billion senior notes offering, comprising notes due 2030 and 2036. Proceeds will redeem existing 2027 notes and be used for general corporate purposes, providing financial flexibility. The offering is under an effective shelf registration with the SEC, and the deal is expected to close June 18, 2025.

    2025年6月4日
  • Norfolk Southern to Present at 2025 Wells Fargo Industrials & Materials Conference

    Norfolk Southern (NSC) will participate in the 2025 Wells Fargo Industrials and Materials Conference. Executives John Orr and Jason Zampi will discuss the company’s operational and financial outlook via webcast on June 10, 2025. A recorded presentation will be available afterward. Norfolk Southern, with roots dating back to 1827, operates a large freight network across 22 states and focuses on sustainability.

    2025年6月4日
  • Weekly Share Repurchase Program Transactions

    SBM Offshore reports on its EUR141 million share repurchase program, running from April 24, 2025. As of June 4, 2025, 13.46% of the program is complete, with 1,003,324 shares repurchased at an average price of EUR 18.94. Details of recent transactions are provided, including recent repurchases. Comprehensive information is available on the company’s website.

    2025年6月4日
  • VTEX Named Customers’ Choice for Digital Commerce in 2025 Gartner® Voice of the Customer Report: Second Year Running

    VTEX has been recognized as a Customers’ Choice in the 2025 Gartner Voice of the Customer for Digital Commerce report for the second consecutive year. With a 98% customer recommendation rate and an impressive overall score of 4.8 out of 5 stars based on 63 reviews, VTEX is the only digital commerce platform to achieve this distinction two years in a row. The report highlights customer satisfaction and the platform’s success for global enterprise brands.

    2025年6月4日
  • Millions of Exam Papers Embark on Journey: Police Escort Postal Trucks Nationwide

    As the 2025 Gaokao nears, China is undertaking a massive logistical operation: nationwide distribution of exam papers. China Post, with police escorts and advanced technology like Beidou, is ensuring secure transport for over 13.35 million examinees. The operation highlights the exam’s importance and underlines the need for public vigilance and cooperation.

    2025年6月4日